Interview with Omar Ehsan, General Manager, IMS Health South Africa
Mr. Ehsan, you are the General Manager of IMS Africa since January 2010. What is the strategic importance of South Africa for IMS Global and for your personal country portfolio?…
Address: Ground Floor, Building 5, Tuscany Office Park, 6 Coombe Place, Rivonia, 2129, Johannesburg, South Africa
Tel: +2711 2345701/2
Web: http://accord-healthcare.com/
A wholly owned subsidiary and the marketing arm of Intas Pharmaceuticals Ltd., India Accord is engaged in all the licensing related activities and pharmaceutical product trading in various Therapeutic Segments in the regulatory markets. The company leverages the manufacturing support from INTAS.
Accord Healthcare has its global matrix spread to USA, UK, Spain, Canada, Australia & New Zealand, South Africa, Brazil, Mexico, Peru, Vietnam, and Kenya.
Accord is committed to maximise customer satisfaction by introducing innovative, quality products in the market.
Accord Healthcare South Africa specializing in Oncology products as well as having a basket of products in the following therapeutic areas:
Biologicals, Immunosuppression, Cardio Vascular, Central Nervous System, Anti-diabetic, Nausea, Osteoporosis, Autonomic, Respiratory, GIT, Ophthalmics and Dermatologicals.
Clonazepam
Mycophenolate Mofetil
Levetiracetam Tablets
Mr. Ehsan, you are the General Manager of IMS Africa since January 2010. What is the strategic importance of South Africa for IMS Global and for your personal country portfolio?…
In 2010, South Africa officially joined the BRICS grouping. The Indian and Russian work environments are familiar to you, considering your significant experience in these countries. How would you compare…
Ms Beaumont, can you describe the association to our readers and its main objectives? Innovative Medicines South Africa (IMSA) represents manufacturers of research-based medicines, ie they market the products of…
See our Cookie Privacy Policy Here
